Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
IMAGINE is a Phase II, randomized, two-arm, chemotherapy controlled modular trial in subjects
with histologically confirmed, resectable gastric cancer (GC) or adenocarcinoma of the
gastroesophageal junction (AEG). Up to 22 patients will be included in each arm of the trial.